BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26621176)

  • 21. Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection.
    Horvatits T; Schulze Zur Wiesch J; Polywka S; Buescher G; Lütgehetmann M; Hussey E; Horvatits K; Peine S; Haag F; Addo MM; Lohse AW; Weiler-Normann C; Pischke S
    Pathogens; 2020 Sep; 9(9):. PubMed ID: 32947995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butchering activity is the main risk factor for hepatitis E virus (
    Oluremi AS; Casares-Jimenez M; Opaleye OO; Caballero-Gomez J; Ogbolu DO; Lopez-Lopez P; Corona-Mata D; Rivero-Juarez A; Rivero A
    Front Microbiol; 2023; 14():1247467. PubMed ID: 37822752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High seroprevalence of hepatitis E virus in the Free State province of South Africa.
    Maphumulo SS; Goedhals D; van Rooyen C; Vawda S
    S Afr J Infect Dis; 2024; 39(1):577. PubMed ID: 38628422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of Hepatitis-E Virus-Immunoglobulin G and its association with Chronic Liver Disease.
    Memon MS; Kadir B; Kamani L; Chandio AA
    Pak J Med Sci; 2024; 40(5):1011-1016. PubMed ID: 38827844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence and incidence of hepatitis E virus infection in the general population of Iwate prefecture, Japan: A retrospective cohort study.
    Yoshida Y; Ito A; Eto H; Suzuki A; Abe T; Endo K; Kakisaka K; Oikawa T; Kuroda H; Miyasaka A; Matsumoto T; Takahashi M; Okamoto H
    Hepatol Res; 2024 Jan; 54(1):24-31. PubMed ID: 37635642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection.
    López-López P; Rivero-Juarez A; Frias M; Machuca I; Caballero-Gómez J; Olivas I; Camacho A; Risalde MLA; García-Bocanegra I; Rivero A
    Front Microbiol; 2019; 10():2617. PubMed ID: 31787965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulated metabolites and lipids in serum of patients with acute hepatitis E: A longitudinal study.
    Khan S; Kumar Y; Sharma C; Gupta SK; Goel A; Aggarwal R; Veerapu NS
    J Viral Hepat; 2023 Dec; 30(12):959-969. PubMed ID: 37697495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prevalence of Hepatitis E in a Patient Cohort Presenting With Addictive Injection Behavior.
    Yrondi A; Salles J; Péron JM; Sporer M; Taib S; Gallini A; Noilhan C; Dimeglio C; Entajan F; Crequy M; Izopet J; Schmitt L
    Front Psychiatry; 2019; 10():832. PubMed ID: 31798477
    [No Abstract]   [Full Text] [Related]  

  • 29. Author Correction: Anti-HEV seroprevalence and rate of viremia in a German cohort of dogs, cats, and horses.
    Pischke S; Knoop EV; Mader M; Kling L; Wolski A; Wagner A; Mueller K; Horvatits T; Stiller J; Wisnewski K; Kohn B; Schulze Zur Wiesch J; Groschup MH; Eiden M
    Sci Rep; 2023 Nov; 13(1):20651. PubMed ID: 38001248
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis E virus seroprevalence among schistosomiasis patients in Northeastern Brazil.
    Passos-Castilho AM; de Sena A; Domingues AL; Lopes-Neto EP; Medeiros TB; Granato CF; Ferraz ML
    Braz J Infect Dis; 2016; 20(3):262-6. PubMed ID: 27020708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays.
    Pischke S; Schwarze-Zander C; Bremer B; Lehmann P; Wiegand SB; Gisa A; Behrendt P; Strassburg CP; Manns MP; Wedemeyer H; Rockstroh JK
    Intervirology; 2015; 58(5):283-7. PubMed ID: 26625157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review.
    Alexandrova R; Tsachev I; Kirov P; Abudalleh A; Hristov H; Zhivkova T; Dyakova L; Baymakova M
    Infect Drug Resist; 2024; 17():1021-1040. PubMed ID: 38505248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study.
    Zahedi MJ; Shafieipour S; Hayatbakhsh Abassi MM; Pourjamali N; Nakhaie M; Charostad J; Rezaei Zadeh Rukerd M; Lashkarizadeh MM; Karami Robati F; Dehghani A; Jahani Y; Arabzadeh SAM; Mollaei HR; Ranjbar E
    Iran J Pathol; 2023; 18(2):125-133. PubMed ID: 37600571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis E Virus in the Iberian Peninsula: A Systematic Review.
    Santos-Silva S; da Silva Dias Moraes DF; López-López P; Rivero-Juarez A; Mesquita JR; Nascimento MSJ
    Food Environ Virol; 2023 Sep; 15(3):193-211. PubMed ID: 37434079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of hepatitis E antigen kinetics and its diagnostic utility for prediction of the outcomes of hepatitis E virus genotype 1 infection.
    El-Mokhtar MA; Karam-Allah Ramadan H; Abdel Hameed MR; M Kamel A; A Mandour S; Ali M; Abdel-Malek MAY; M Abd El-Kareem D; Adel S; H Salama E; Khalaf KAB; Sayed IM
    Virulence; 2021 Dec; 12(1):1334-1344. PubMed ID: 34002677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcomes and Prevalence of Hepatitis E Virus (HEV) Among Non-A-C Hepatitis Patients in Egypt.
    Sayed IM; El-Mokhtar MA; Mahmoud MAR; Elkhawaga AA; Gaber S; Seddek NH; Abdel-Wahid L; Ashmawy AM; Alkareemy EAR
    Infect Drug Resist; 2021; 14():59-69. PubMed ID: 33469320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).
    Vázquez-Morón S; Berenguer J; González-García J; Jiménez-Sousa MÁ; Canorea I; Guardiola JM; Crespo M; Quereda C; Sanz J; Carrero A; Hontañón V; Avellón A; Resino S
    Sci Rep; 2019 Feb; 9(1):1143. PubMed ID: 30718554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis E Virus in Industrialized Countries: The Silent Threat.
    Clemente-Casares P; Ramos-Romero C; Ramirez-Gonzalez E; Mas A
    Biomed Res Int; 2016; 2016():9838041. PubMed ID: 28070522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Seroprevalence of hepatitis E virus in patients with hepatitis C and / or infected with HIV].
    López-Fabal MF; Gómez-Garcés JL
    Rev Esp Quimioter; 2015 Dec; 28(6):314-6. PubMed ID: 26621176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain.
    Mateos-Lindemann ML; Diez-Aguilar M; Galdamez AL; Galán JC; Moreno A; Pérez-Gracia MT
    J Med Virol; 2014 Jan; 86(1):71-4. PubMed ID: 24136591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.